Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jan;2(1):20-7.
doi: 10.5812/nephropathol.9093. Epub 2013 Jan 1.

Diabetic nephropathy and antioxidants

Majid Tavafi  1
Affiliations
Review

Diabetic nephropathy and antioxidants

Majid Tavafi. J Nephropathol. 2013 Jan.

Abstract

Context: Oxidative stress has crucial role in pathogenesis of diabetic nephropathy (DN). Despite satisfactory results from antioxidant therapy in rodent, antioxidant therapy showed conflicting results in combat with DN in diabetic patients.

Evidence acquisitions: Directory of Open Access Journals (DOAJ), Google Scholar,Pubmed (NLM), LISTA (EBSCO) and Web of Science have been searched.

Results: Treatment of DN in human are insufficient with rennin angiotensin system (RAS) blockers, so additional agent ought to combine with this management. Meanwhile based on DN pathogenesis and evidences in experimental and human researches, the antioxidants are the best candidate. New multi-property antioxidants may be improved human DN that show high power antioxidant capacity, long half-life time, high permeability to mitochondrion, improve body antioxidants enzymes activity and anti-inflammatory effects.

Conclusions: Based on this review and our studies on diabetic rats, rosmarinic acid a multi-property antioxidant may be useful in DN patients, but of course, needs to be proven in clinical trials studies.

Keywords: Antioxidants; Diabetic nephropathy; Oxidative stress.

PubMed Disclaimer

References

    1. Vasavada N, Agarwal R. Vasavada N, Agarwal RRole of oxidative stress in diabetic nephropathyAdv. Chronic Kidney Dis . 2005;12(2):146–54. - PubMed
    1. Kang ES, Lee GT, Kim BS, Kim CH, Seo GH, Han SJ. et al. Lithospermic acid B ameliorates the development of diabetic nephropathy in OLETF rats. Eur J Pharmacol . 2008;579(1-3):418–25. - PubMed
    1. Shena F, Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. JASN . 2005;16:s30–s33. - PubMed
    1. Singh N, Sharma P, Garg V, Mondal S, Singh A. Antioxidant therapy in diabetic nephropathy. Journal of Pharmacy Research 2011;4(11):4249-51. http://www.doaj.org/doaj?func=...
    1. Giacco F, Brownlee M. Oxidative Stress and Diabetic Complications. Circ Res . 2010;107:1058–70. - PMC - PubMed